JWN
69
-4
URI
68
3
RCL
69
7
HRL
41
2
CF
45
3
DG
30
-4
MAC
70
-2
AVB
67
-7
L
58
-6
AMAT
60
3
PEP
48
-6
TAP
38
-3
ED
40
-3
MAR
50
2
PNC
48
-4
BMY
30
-3
PRU
53
-7
CI
45
-3
PG
61
-2
PGR
67
-2
JWN
69
-4
URI
68
3
RCL
69
7
HRL
41
2
CF
45
3
DG
30
-4
MAC
70
-2
AVB
67
-7
L
58
-6
AMAT
60
3
PEP
48
-6
TAP
38
-3
ED
40
-3
MAR
50
2
PNC
48
-4
BMY
30
-3
PRU
53
-7
CI
45
-3
PG
61
-2
PGR
67
-2
Financhill
Back

Apellis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
43.22
Seasonality Move:
9.35%
Sell
32

ALNY
Alnylam Pharmaceuticals

Last Price:
150.13
Seasonality Move:
19.79%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $43.22. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $150.24. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $43.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $150.24
    The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.83 Sell
Relative Strength Index (14 RSI): 40.9 Sell
Chaikin Money Flow: 822657 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.64 - 48.9) Sell
Bollinger Bands (100): (49.68 - 66.88) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 51.38 Buy
Chaikin Money Flow: 234808 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (145 - 151.3) Buy
Bollinger Bands (100): (144.24 - 178.48) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.15 Buy
20-day SMA: 45.09 Sell
50-day SMA: 51.11 Sell
200-day SMA: 51.84 Sell
8-day EMA: 42.69 Buy
20-day EMA: 45 Sell
50-day EMA: 50.12 Sell
200-day EMA: 55.46 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.74 Buy
20-day SMA: 148.82 Buy
50-day SMA: 149.26 Buy
200-day SMA: 168.98 Sell
8-day EMA: 149.82 Buy
20-day EMA: 149.52 Buy
50-day EMA: 151.53 Sell
200-day EMA: 167.11 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.34 per share, an increase this year of $3.60 per share, and an increase next year of $2.16 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):